#UFC 300
#PFL Europe 1 2024
#UFC 301
#UFC 299
#UFC on ESPN 55
#PFL 3 2024 Regular Season
#Max Holloway
#UFC on ABC 6
#Justin Gaethje
#UFC 298
#UFC 302
#UFC on ESPN 56
#Alexsandro Pereira
#UFC Fight Night 241
#UFC 297
#UFC Fight Night 240
#UFC on ESPN 54
#Jamahal Hill
#UFC 303
#Oktagon MMA - Oktagon 56: Aby vs. Creasey
Male vs. Female at Shooto Brazil 45, Antonio Silva Fails UFC FN 33 Drug Test on MMA Newsmakers
- Posted by uber on Dec 18, 2013
- 1508 views
Get UFC Tickets
Use VPN if this video is blocked in your country.
Report here if this video is not working.
Disclaimer DMCA
Use VPN if this video is blocked in your country.
Report here if this video is not working.
Disclaimer DMCA
http://fightnetwork.com - Fight Network's John Pollock, John Ramdeen and Robin Black give us the latest in MMA including Shooto Brazil announcing bout featuring male vs. female fighter, Antonio "Bigfoot" Silva fails UFC Fight Night 33 post-fight drug test with elevated testosterone; forfeits share of $50K Fight of the Night bonus to Mark Hunt and Carlos Condit vs. Tyron Woodley set for UFC 171 in Dallas, TX. on Newsmakers.
For additional coverage of MMA, boxing and pro-wrestling check out http:
Related Merch
Recent Posts
What’s Next for Jamahal Hill, Boxer Anthony Sims Jr. Talks What UFC Gets Right | UFC Unfiltered
- 44 minutes ago
- 0 views
UFC community SUSPRISED due to Ryan Garcia vs Sean O'Malley bout being in works, Alex Pereira reacts
- an hour ago
- 1 views
Tatiana Suarez hopes to fight Zhang Weili at the Sphere, is confident she’d win by sub | ESPN MMA
- an hour ago
- 2 views
UFC 301: ALEX PEREIRA's Bold Move to Challenge TOM ASPINALL for Heavyweight Title - Tale of the Tape
- 2 hours ago
- 1 views
Related Videos
Disclaimer:
None of the videos shown here are actually hosted on this server. The video streams
are provided solely by this site's users. The owner of this site (mma-core.com)
holds NO RESPONSIBILITY if these videos are misused in any way and cannot be held
responsible for what its users post, or any other actions of its users. Please read
our Terms of Service for more information.